Intervention for Tobacco Use for People Experiencing Homelessness
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO ·
Trial Information
Current as of November 12, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at ways to help people who are experiencing homelessness stop using tobacco products like cigarettes. The study will take place in California, specifically in San Francisco and Los Angeles. It aims to better understand tobacco use in this community and offer support to those who want to quit smoking or using other tobacco products.
People who are between 65 and 74 years old and currently experiencing homelessness may be eligible to join the study. Both men and women can participate. If you join, you can expect to receive help and treatment designed to support quitting tobacco use. Since this is an early phase study, it’s focused on learning how well these approaches might work and how to best provide care to this group. The study is not yet recruiting participants, but it hopes to offer valuable support to those who want to live healthier, tobacco-free lives.
Gender
ALL
Eligibility criteria
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Maya Vijayaraghavan, MD
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported